Prospective Evaluation to Establish a Dose Response for Clinical Oral Mucositis in Patients Undergoing Head-and-Neck Conformal Radiotherapy

Samir Narayan, Joerg Lehmann, Matthew A. Coleman, Andrew Vaughan, Claus Chunli Yang, Danny Enepekides, Gregory Farwell, James A. Purdy, Grace Laredo, Kerry Nolan, Francesca S. Pearson, Srinivasan Vijayakumar

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Purpose: We conducted a clinical study to correlate oral cavity dose with clinical mucositis, perform in vivo dosimetry, and determine the feasibility of obtaining buccal mucosal cell samples in patients undergoing head-and-neck radiation therapy. The main objective is to establish a quantitative dose response for clinical oral mucositis. Methods and Materials: Twelve patients undergoing radiation therapy for head-and-neck cancer were prospectively studied. Four points were chosen in separate quadrants of the oral cavity. Calculated dose distributions were generated by using AcQPlan and Eclipse treatment planning systems. MOSFET dosimeters were used to measure dose at each sampled point. Each patient underwent buccal sampling for future RNA analysis before and after the first radiation treatment at the four selected points. Clinical and functional mucositis were assessed weekly according to National Cancer Institute Common Toxicity Criteria, Version 3. Results: Maximum and average doses for sampled sites ranged from 7.4-62.3 and 3.0-54.3 Gy, respectively. A cumulative point dose of 39.1 Gy resulted in mucositis for 3 weeks or longer. Mild severity (Grade ≤ 1) and short duration (≤1 week) of mucositis were found at cumulative point doses less than 32 Gy. Polymerase chain reaction consistently was able to detect basal levels of two known radiation responsive genes. Conclusions: In our sample, cumulative doses to the oral cavity of less than 32 Gy were associated with minimal acute mucositis. A dose greater than 39 Gy was associated with longer duration of mucositis. Our technique for sampling buccal mucosa yielded sufficient cells for RNA analysis using polymerase chain reaction.

Original languageEnglish
Pages (from-to)756-762.e4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume72
Issue number3
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Keywords

  • Buccal mucosa
  • Head-and-neck cancer
  • Mucositis
  • RNA analysis
  • Radiation therapy

Fingerprint Dive into the research topics of 'Prospective Evaluation to Establish a Dose Response for Clinical Oral Mucositis in Patients Undergoing Head-and-Neck Conformal Radiotherapy'. Together they form a unique fingerprint.

  • Cite this

    Narayan, S., Lehmann, J., Coleman, M. A., Vaughan, A., Yang, C. C., Enepekides, D., Farwell, G., Purdy, J. A., Laredo, G., Nolan, K., Pearson, F. S., & Vijayakumar, S. (2008). Prospective Evaluation to Establish a Dose Response for Clinical Oral Mucositis in Patients Undergoing Head-and-Neck Conformal Radiotherapy. International Journal of Radiation Oncology Biology Physics, 72(3), 756-762.e4. https://doi.org/10.1016/j.ijrobp.2008.01.060